Skip to content

Delcath Systems DCTH Debt-to-equity

Debt-to-equity at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
0.5×-0.1×
Boston Scientific logo
Boston ScientificBSX
-0.5×
Altimmune logo
AltimmuneALT
0.1×+0.1×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.2×+0.1×
Wave Life Sciences logo
Wave Life SciencesWVE
-0.1×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0.1×0.0×

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

Based on the most recent quarter.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's debt-to-equity?
Delcath Systems (DCTH) reported debt-to-equity of 0× in Q1 2026.
How has Delcath Systems's debt-to-equity changed year-over-year?
Delcath Systems's debt-to-equity decreased by 37.0% year-over-year, from 0× to 0×.
What is the long-term trend for Delcath Systems's debt-to-equity?
Over 4 years (2020 to 2025), Delcath Systems's debt-to-equity has grown at a -33.4% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.